Skip to main content

M Aksenova

First name:
M
Last name:
Aksenova
Aksenova, M., Butterfield, D., Zhang, S., Underwood, M., & Geddes, J. (2002). Increased protein oxidation and decreased creatine kinase BB expression and activity after spinal cord contusion injury. Journal of Neurotrauma, 19(4), 491-502. https://doi.org/10.1089/08977150252932433
Varadarajan, S., Kanski, J., Aksenova, M., Lauderback, C., & Butterfield, D. (2001). Different mechanisms of oxidative stress and neurotoxicity for Alzheimer’s A beta(1--42) and A beta(25--35). Journal of the American Chemical Society, 123(24), 5625-31. https://doi.org/10.1021/ja010452r (Original work published 2001)
Kanski, J., Drake, J., Aksenova, M., Engman, L., & Butterfield, D. (2001). Antioxidant activity of the organotellurium compound 3- 4-(N,N-dimethylamino)benzenetellurenyl propanesulfonic acid against oxidative stress in synaptosomal membrane systems and neuronal cultures. Brain Research, 911(1), 12-21. https://doi.org/10.1016/s0006-8993(01)02541-0 (Original work published 2001)
Kanski, J., Varadarajan, S., Aksenova, M., & Butterfield, D. (2002). Role of glycine-33 and methionine-35 in Alzheimer’s amyloid beta-peptide 1-42-associated oxidative stress and neurotoxicity. Biochimica et Biophysica Acta, 1586(2), 190-8. https://doi.org/10.1016/s0925-4439(01)00097-7 (Original work published 2002)
Kanski, J., Aksenova, M., Stoyanova, A., & Butterfield, D. (2002). Ferulic acid antioxidant protection against hydroxyl and peroxyl radical oxidation in synaptosomal and neuronal cell culture systems in vitro: structure-activity studies. The Journal of Nutritional Biochemistry, 13(5), 273-281. https://doi.org/10.1016/s0955-2863(01)00215-7
Kanski, J., Aksenova, M., Schöneich, C., & Butterfield, D. (2002). Substitution of isoleucine-31 by helical-breaking proline abolishes oxidative stress and neurotoxic properties of Alzheimer’s amyloid beta-peptide. Free Radical Biology & Medicine, 32(11), 1205-11. https://doi.org/10.1016/s0891-5849(02)00821-3 (Original work published 2002)
Castegna, A., Aksenov, M., Aksenova, M., , Klein, J., Pierce, W., … Butterfield, D. (2002). Proteomic identification of oxidatively modified proteins in Alzheimer’s disease brain. Part I: creatine kinase BB, glutamine synthase, and ubiquitin carboxy-terminal hydrolase L-1. Free Radical Biology & Medicine, 33(4), 562-71. https://doi.org/10.1016/s0891-5849(02)00914-0 (Original work published 2002)
Kanski, J., Aksenova, M., & Butterfield, D. (2002). The hydrophobic environment of Met35 of Alzheimer’s Abeta(1-42) is important for the neurotoxic and oxidative properties of the peptide. Neurotoxicity Research, 4(3), 219-23. https://doi.org/10.1080/10298420290023945
Drake, J., Sultana, R., Aksenova, M., , & Butterfield, D. (2003). Elevation of mitochondrial glutathione by gamma-glutamylcysteine ethyl ester protects mitochondria against peroxynitrite-induced oxidative stress. Journal of Neuroscience Research, 74(6), 917-27. https://doi.org/10.1002/jnr.10810 (Original work published 2003)